Erlotinib in lung cancer - molecular and clinical predictors of outcome.
Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA.
Tsao MS, et al. Among authors: liu n.
N Engl J Med. 2005 Jul 14;353(2):133-44. doi: 10.1056/NEJMoa050736.
N Engl J Med. 2005.
PMID: 16014883
Free article.
Clinical Trial.